Chen et al. found that PAF was upregulated in NSCLC samples in comparison to the normal controls, which was associated with the poor prognosis of NSCLC patients, and the radiosensitivity of NSCLC cells could be improved with the decrease of PAF expression level [11]. This evidence concerns the gene PCLAF and non-small cell lung carcinoma.